Evidence map›Paper›PMID 40251598›Full record

ArticleJournal of orthopaedic surgery and research2025

MIR155HG suppresses the osteogenic differentiation of bone marrow mesenchymal stem cells through regulating miR-155-5p and DKK1 expression.

Weimin Li, Cheng Yang, Jiamu Xu, Dongcheng Ran, Chunqing Wang

Abstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Weimin Li *Department of Orthopedic, The Fourth People's Hospital of Guiyang, Guiyang Guizhou, 550002, China.
Cheng Yang *Department of Orthopedic, Guizhou Hospital of Beijing Jishuitan Hospital, Guiyang Guizhou, 550014, China.
Jiamu XuSchool of Clinical Medicine, Guizhou Medical University, Guiyang, 550004, China.
Dongcheng RanSchool of Clinical Medicine, Guizhou Medical University, Guiyang, 550004, China.
Chunqing WangDepartment of Traumatology and Orthopedics, Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Yunyan District, Guiyang, Guizhou, 550004, China. wangchunqing@gmc.edu.cn.

Funding

Guizhou Medical University 22NSFCP46National Natural Science Foundation of China 82060271
6 · The paper itself

Abstract

backgroundIncreasing evidence has demonstrated that non-coding RNAs, including the lncRNA MIR155HG, are involved in the pathogenesis of postmenopausal osteoporosis (PMOP). In the current study, we studied MIR155HG function in regulation of osteogenic differentiation and tried to reveal the underlying mechanisms.

methodsForty blood samples taken from 20 PMOP patients (PMOP group) and 20 postmenopausal individuals without osteoporosis (control group) were used to compare the contents of MIR155HG and miR-155-5p via RT-PCR. Alizarin red S staining and ALP staining were used to evaluate the osteogenic differentiation potential of bone marrow mesenchymal stem cells (BMSCs).

resultsElevated levels of MIR155HG and miR-155-5p were observed in the blood samples of the PMOP group. Upregulation of MIR155HG resulted in decreased expression of OPN, OSX, ALP, RUNX2 and β-catenin but increased DKK1 expression, together with decreased Alizarin red S + and ALP + staining areas. However, downregulation of DKK1 did not obviously change the above indices induced by MIR155HG upregulation. Further experiments revealed that MIR155HG caused an increase in the expression of miR-155-5p, which also serves as an inhibitor of the osteogenic differentiation of BMSCs through binding to β-catenin. Consistent with DKK1 knockdown, downregulation of miR-155-5p only also did not obviously reverse the repressive effect of MIR155HG on osteoblastic differentiation, but downregulation of DKK1 and miR-155-5p synchronously restored the osteogenic differentiation ability of BMSCs suppressed by MIR155HG overexpression.

conclusionMIR155HG suppressed the osteoblastic differentiation of BMSCs by regulating miR-155-5p and DKK1 expression. Either inhibition of miR-155-5p and DKK1 or direct suppression of MIR155HG may be effective approaches for treating PMOP.

Indexed as

Bone Marrow CellsCell DifferentiationIntercellular Signaling Peptides and ProteinsMesenchymal Stem CellsMicroRNAsOsteogenesisOsteoporosis, PostmenopausalRNA, Long NoncodingAgedCells, CulturedFemaleHumansMiddle AgedDKK1 protein, humanIntercellular Signaling Peptides and ProteinsMicroRNAsMIRN155 microRNA, humanRNA, Long NoncodingBone marrow mesenchymal stem cellsDKK1miR-155-5pMIR155HGOsteogenic differentiation

Identifiers

PMID40251598
PMCPMC12008851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.